Reports and Data's analysis shows that the global Sacral Neuromodulation Market was valued at USD 2,432.9 Million in 2020 and is expected to reach USD 3,498.2 Million by 2032, at a CAGR of 4.94%.
The research presents a comprehensive examination of Sacral Neuromodulation and their application in treating overactive bladder. This condition, characterized by symptoms such as urgency, frequency, and incontinence, affects a substantial portion of the population, particularly as they age. For the past twenty years, Sacral Neuromodulation, also referred to as sacral nerve stimulation, have emerged as a popular and efficacious treatment option for overactive bladder and bowel issues. Essentially, the primary objective of Sacral Neuromodulation is to enhance the communication between the brain and the bladder/bowel for improved coordination.
Get a free sample PDF of the report, visit @
https://www.reportsanddata.com/download-free-sample/1487
The global market is driven by factors such as an increasing geriatric population, a rise in neurological diseases, and the failure of conventional treatments (exercise, changes in lifestyle, diet) to cure Sacral Neuromodulation. However, adverse effects and complications in some Sacral Neuromodulation treatments are the major hindrances for market growth from 2019 to 2028.
According to the report, the Sacral Neuromodulation market is dominated by North America, which generates the highest revenue and holds 35.5% of the total market share. This is attributed to the region's technological advancements and increased awareness about Sacral Neuromodulation. Europe follows closely with 31.2% of the total market share. Implantable Sacral Neuromodulation are preferred globally compared to external devices, with implantable devices accounting for 62.5% of the total market share, while external devices make up 33.3%.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/1487
Medtronic is the dominating player in manufacturing Sacral Neuromodulation instruments and devices in the global market. In 2015, Medtronic had net sales worth USD 3.8 billion in neuromodulation, with gastrointestinal and urological devices being the prime factors for the rapid growth of Medtronic. Axonics Modulation Technologies acquired investments in Sacral Neuromodulation worth USD 38.5 million to study OAB implants extensively in North America and Europe and is expected to surpass medical device giant Medtronic’s popular and successful Interstim system in the coming future.
Axonics' Sacral Neuromodulation system is rechargeable, has a guaranteed lifetime of up to 15 years (three times longer than Medtronic's Interstim), and is 60% smaller than the Interstim device.
The report also highlights that there are tremendous opportunities for companies like Axonics to enter the market since only a handful of players are currently in the market. Revenue from the sale of Sacral Neuromodulation devices is estimated to rise around USD 600 million annually, with nearly 30,000 devices implanted in patients in 2014 alone. Revenue for this market is estimated to grow to over USD 1 billion by the end of 2019.
The key players in the global market are Cyberonics, St Jude Medicals, Boston Scientific, and Medtronic. The report segments the Sacral Neuromodulation market based on product, application, and region. The product segments include Sacral Neuromodulation and Sacral Neuromodulation, while the application segment includes urinary incontinence and urge incontinence. The regional outlook includes North America, Europe, Asia Pacific, the Middle East Africa, and Latin America.
Despite the potential growth opportunities in the market, associated side effects related to Sacral Neuromodulation treatments and a lack of awareness about Sacral Neuromodulation are likely to hinder the market growth during the forecast period.
Request customization of the report @
https://www.reportsanddata.com/request-customization-form/1487
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Browse for more reports…